Insider Transactions in Q1 2025 at Johnson & Johnson (JNJ)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 13
2025
|
Elizabeth Forminard Executive VP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
651
+6.75%
|
-
|
|
Feb 13
2025
|
Vanessa Broadhurst EVP, Global Corp Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
408
+1.98%
|
-
|
|
Feb 07
2025
|
Joseph J Wolk Exec VP, CFO |
SELL
Open market or private sale
|
Direct |
13,015
-100.0%
|
$1,991,295
$153.89 P/Share
|
|
Feb 07
2025
|
Joseph J Wolk Exec VP, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
13,015
+50.0%
|
$1,301,500
$100.06 P/Share
|
|
Feb 07
2025
|
Jennifer L Taubert EVP, WWC. Innovative Medicine |
SELL
Payment of exercise price or tax liability
|
Direct |
47,436
-22.23%
|
$7,257,708
$153.12 P/Share
|
|
Feb 07
2025
|
Jennifer L Taubert EVP, WWC. Innovative Medicine |
BUY
Exercise of conversion of derivative security
|
Direct |
58,504
+21.52%
|
$5,850,400
$100.06 P/Share
|
|
Feb 07
2025
|
Kathryn E Wengel EVP, Chief TO and Risk Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
26,076
-22.67%
|
$3,989,628
$153.12 P/Share
|
|
Feb 07
2025
|
Kathryn E Wengel EVP, Chief TO and Risk Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
32,762
+22.17%
|
$3,276,200
$100.06 P/Share
|
|
Feb 07
2025
|
Joaquin Duato CEO and Chairman of the Board |
SELL
Payment of exercise price or tax liability
|
Direct |
100,643
-20.55%
|
$15,398,379
$153.12 P/Share
|
|
Feb 07
2025
|
Joaquin Duato CEO and Chairman of the Board |
BUY
Exercise of conversion of derivative security
|
Direct |
126,369
+20.51%
|
$12,636,900
$100.06 P/Share
|